4.6 Article

Utilization of health care services in cancer patients with elevated fear of cancer recurrence

Journal

PSYCHO-ONCOLOGY
Volume 27, Issue 8, Pages 1958-1964

Publisher

WILEY
DOI: 10.1002/pon.4748

Keywords

cancer; complementary and alternative medicine; fear of cancer recurrence; health care utilization; longitudinal study; oncology; psychotropic medication usage

Funding

  1. Canadian Institutes of Health Research [MOP-69073]

Ask authors/readers for more resources

BackgroundCancer patients commonly report experiencing fear of cancer recurrence (FCR), which may lead to several negative consequences. This study aimed at examining whether clinical levels of FCR are linked to a greater use of health care services. MethodThis is a secondary analysis of a longitudinal study of 962 cancer patients on the epidemiology of cancer-related insomnia. They completed the Fear of Cancer Recurrence InventoryShort form (FCRI-SF) and reported information on their consultations (medical, psychosocial, and complementary and alternative medicine [CAM]) and medication usage (anxiolytics/hypnotics and antidepressants) at 6 time points over an 18-month period. ResultsResults indicated that clinical FCR at baseline was associated with greater consultation rates of medical and psychosocial professionals and a greater usage of anxiolytics/hypnotics and antidepressants. No significant association was found between the FCR level and use of CAM services. While consultation rates of medical and CAM professionals and usage of antidepressants generally increased over time, consultation rates of psychosocial professionals and usage of anxiolytics/hypnotics tended to decrease. ConclusionsCancer patients with clinical levels of FCR are more likely to consult health care providers and to use psychotropic medications, which may translate into significant costs for society and the patients themselves.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available